MedCity News January 25, 2026
The contract research organization consolidation trend continues with Worldwide Clinical Trials striking a deal for Catalyst Clinical Research, which has particular expertise in oncology. Worldwide is a portfolio company of Kohlberg, a private equity firm.
Mergers and acquisition activity in pharmaceutical services is common, particularly between private equity-backed companies looking to add new capabilities while growing their client rosters and revenue. The latest deal has Worldwide Clinical Trials agreeing to buy Catalyst Clinical Research, a contract research organization (CRO) that brings expertise in oncology clinical studies.
Financial terms of the acquisition were not disclosed, but Axios reported that Research Triangle Park, North Carolina-based Worldwide is paying $500 million. The companies expect to close the transaction in the current quarter.
Worldwide...
Today's Sponsors
Today's Sponsor